High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts

High Rabbit-Antihuman Thymocyte Globulin Levels Are Associated with Low Likelihood of Graft-vs-Host Disease and High Likelihood of Posttransplant Lymphoproliferative Disorder

(2010) Peter J. Podgorny et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Treatment-dependent Loss of Polyfunctional CD8+ T-cell Responses in HIV-infected Kidney Transplant Recipients Is Associated with Herpesvirus Reactivation

(2009) O. Gasser et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Role of Antithymocyte Globulin and Granulocyte-Colony Stimulating Factor-Mobilized Bone Marrow in Allogeneic Transplantation for Patients with Hematologic Malignancies

(2009) Xing-hua Chen et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Successful Prevention of Acute Graft-versus-Host Disease Using Low-Dose Antithymocyte Globulin after Mismatched, Unrelated, Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia

(2009) Hee-Je Kim et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

(2009) O. Landgren et al.   BLOOD

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

(2009) A Bacigalupo et al.   BONE MARROW TRANSPLANTATION

Viral disease prevention after hematopoietic cell transplantation

(2009) J Zaia et al.   BONE MARROW TRANSPLANTATION

Anti-T-cell globulin: an essential ingredient for haematopoietic cell transplantation?

(2009) Francesco Frassoni   LANCET ONCOLOGY

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

(2009) Jürgen Finke et al.   LANCET ONCOLOGY

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction

(2009) H. Omar et al.   Transplant Infectious Disease

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

(2009) J. Styczynski et al.   Transplant Infectious Disease

Comparison of Two Doses of Antithymocyte Globulin in Patients Undergoing Matched Unrelated Donor Allogeneic Stem Cell Transplantation

(2008) Francis Ayuk et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Outcomes following HSCT Using Fludarabine, Busulfan, and Thymoglobulin: A Matched Comparison to Allogeneic Transplants Conditioned with Busulfan and Cyclophosphamide

(2008) Christopher N. Bredeson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute

(2008) H-A Hou et al.   BONE MARROW TRANSPLANTATION

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

(2008) J Styczynski et al.   BONE MARROW TRANSPLANTATION

Epstein–Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients

(2008) Ellen Meijer et al.   CURRENT OPINION IN HEMATOLOGY

Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors

(2008) Francis Ayuk et al.   EXPERIMENTAL HEMATOLOGY